DNAPrint Genomics, Inc. (DNAG)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 30, 2026
DNAPrint Genomics Market Cap
DNAPrint Genomics has a market cap or net worth of $1.3 thousand as of October 30, 2026. It is the 52,464th most valuable company in the world and the 8,389th biggest in the United States.
Market Cap
1.30K
Enterprise Value
n/a
Revenue
1.93M
Global Rank
Country Rank
#8,389 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 1996, DNAPrint Genomics's market cap has decreased from 12.11M to 1.30K, a decrease of -99.99%. That is a compound annual growth rate of -25.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.30K | - |
| Dec 30, 2025 | 1.30K | - |
| Dec 13, 2024 | 1.30K | - |
| Dec 28, 2023 | 1.30K | - |
| Dec 30, 2022 | 1.30K | - |
| Dec 31, 2021 | 1.30K | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |
| Evelo Biosciences | 1.90K |
| ZIM Corporation | 1.63K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| EV Biologics | 1.02K |
| Virpax Pharmaceuticals | 994.00 |